<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.163866.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>The prevalence of intraventricular hemorrhage and its related risk factors among preterm neonates</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: awaiting peer review]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>AlGhamdi</surname>
                        <given-names>Mohammad A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0009-0004-3946-2226</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Alnaim</surname>
                        <given-names>Abdulrahman A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>AlGhadeer</surname>
                        <given-names>Hussain A</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <uri content-type="orcid">https://orcid.org/0009-0002-9128-8005</uri>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Aldajani</surname>
                        <given-names>Alaa A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alabdulqader</surname>
                        <given-names>Muneera A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alarbash</surname>
                        <given-names>Abdullah A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alkhamis</surname>
                        <given-names>Abdullah S.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>AlBassam</surname>
                        <given-names>Layan Y.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>AlQahtani</surname>
                        <given-names>Fai A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Abdulghani</surname>
                        <given-names>Dina W.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0009-0000-3202-9826</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Al Noaim</surname>
                        <given-names>Khalid</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-5469-1220</uri>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alahmari</surname>
                        <given-names>Abdulaziz A.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-2706-324X</uri>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alhejji</surname>
                        <given-names>Muntather S.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alamer</surname>
                        <given-names>Eman F.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Aldandan</surname>
                        <given-names>Hawra M.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Al Ostaz</surname>
                        <given-names>Sameer S.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Alharbi</surname>
                        <given-names>Anas M.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Neonatology, Collage of medicine, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Alkhobar, Saudi Arabia</aff>
                <aff id="a2">
                    <label>2</label>Department of Pediatrics, College of Medicine, King Faisal University,, AlAhsa, Saudi Arabia</aff>
                <aff id="a3">
                    <label>3</label>Department of Pediatrics, Maternity and Children Hospital, AlAhsa, Saudi Arabia</aff>
                <aff id="a4">
                    <label>4</label>Department of Pediatrics, College of Medicine, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Alkhobar, Saudi Arabia</aff>
                <aff id="a5">
                    <label>5</label>Department of Pediatrics, Maternity and Children Hospital, Dammam, Saudi Arabia</aff>
                <aff id="a6">
                    <label>6</label>Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:Dr.a.alnaim@gmail.com">Dr.a.alnaim@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>6</day>
                <month>6</month>
                <year>2025</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2025</year>
            </pub-date>
            <volume>14</volume>
            <elocation-id>562</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>20</day>
                    <month>5</month>
                    <year>2025</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2025 AlGhamdi MA et al.</copyright-statement>
                <copyright-year>2025</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/14-562/pdf"/>
            <abstract>
                <sec>
                    <title>Introduction</title>
                    <p>Intraventricular hemorrhage (IVH) is a serious concern for preterm infants and can predispose such infants to brain injury and poor neurodevelopmental outcomes.</p>
                </sec>
                <sec>
                    <title>Aim</title>
                    <p>The present study aimed to determine the frequency of IVH and its risk factors in the premature newborns admitted to the Neonatal Intensive Care Unit (NICU) at King Fahd University Hospital.</p>
                </sec>
                <sec>
                    <title>Methodology</title>
                    <p>This cross-sectional study involved 201 preterm neonates admitted at King Fahd University Hospital, Khobar, Saudi Arabia over a period of 7 years (from 2016 to 2023). These neonates were diagnosed by cranial ultrasound. IVH was classified into four grades based on Papile classification. The frequency of IVH was compared across various attributing factors i.e., gestational age at delivery, gender, birth weight, mode of delivery, and maternal antenatal steroids.</p>
                </sec>
                <sec>
                    <title>Results</title>
                    <p>Two hundred and one patients were analyzed (male 50.7% vs. female 49.3%). 51.2% had a gestational age of 29 weeks or less. More than half (54.2%) had a birth weight of &#x2264;1200g. The incidence of IVH in a 7-year duration was 41.8%, with stage 1 (41.7%) and stage 2 (34.5%) being the most common IVH stages. Multivariate regression analysis revealed that CHD, seizure, and ROP were identified as the significant independent predictors of IVH among preterm infants.</p>
                </sec>
                <sec>
                    <title>Conclusion</title>
                    <p>IVH in premature infants remains a complex and delicate issue in neonatology. An integrated approach covering both prevention and treatment is essential to minimize the negative impact of this complication on the neurological development of premature infants.</p>
                </sec>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Intraventricular hemorrhage</kwd>
                <kwd>prematurity</kwd>
                <kwd>low birth weight</kwd>
                <kwd>cranial ultrasound</kwd>
                <kwd>Saudi Arabia</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec6" sec-type="intro">
            <title>Introduction</title>
            <p>Regardless of gestational age, low birth weight infants are born weighing less than 2.5 kg, and preterm infants are born at less than 37 weeks gestational age. For newborns and children under five, preterm birth is the primary cause of mortality and morbidity.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> The survival rate of preterm infants has increased dramatically in the last 20 years due to advancements in neonatal perinatal services. This progress is a result of increased prenatal steroid use, surfactant therapy, better respiratory and nutritional management, and other advancements in prenatal, perinatal, and neonatal care.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> The high morbidities of these preterm infants, which are linked to a higher incidence of adverse neurodevelopmental outcomes, continue to be a serious concern despite this improvement. Intraventricular hemorrhage (IVH) is one of the main morbidities that seriously impairs mental retardation, cerebral palsy, and immediate mortality.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup>
            </p>
            <p>In preterm infants, the overall incidence of IVH is approximately 36%, and the incidence rises with decreasing gestational age and birth weight.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>,
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> It affects roughly 52% of preterm infants born at less than 28 weeks&#x2019; gestation and 45% of extremely preterm infants weighing less than 750 g at birth.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>,
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> Ninety percent of IVH cases happen within three days of birth, and fifty percent happen within one day following birth.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>,
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup> The Papile system divides IVH into four grades, which is helpful in assessing the phenomenon and predicting the outcome during the neonatal period as well as during the follow-up period.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> The following are known risk factors for IVH: birth weight, asphyxia, hypoxia, infection, coagulation dysfunction, twins, intrauterine infection, mechanical ventilation, respiratory distress syndrome requiring surfactant treatment, placenta abnormalities such as placenta abruption.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> The overall mortality risk was comparable for infants with (4&#x2013;7%) and without (10%) IVH of grade one, and it was significantly higher for infants with higher IVH values, specifically 8&#x2013;10% for grade two, 18% for grade three, and approximately 40% for grade four.
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>,
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup>
            </p>
            <p>The survival rate of extremely preterm infants has increased due to advancements in neonatal intensive care, which has consequently increased the number of infants at high risk of developing IVH.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup> In order to determine the prevalence, related risk factors, and short-term consequences of intraventricular hemorrhage (IVH) among preterm neonates at King Fahd University Hospital in Khobar, Saudi Arabia, this study was conducted.</p>
        </sec>
        <sec id="sec7" sec-type="methods">
            <title>Methods</title>
            <sec id="sec8">
                <title>Aim of the study</title>
                <p>To determine the prevalence, associated risk factors and short-term outcomes of intraventricular haemorrhage (IVH) among preterm neonates in King Fahd University Hospital, Khobar, Saudi Arabia.</p>
            </sec>
            <sec id="sec9">
                <title>Rational and importance</title>
                <p>The assessment of disease burden, the distribution of public health resources, and the goals of clinical research may all benefit from a understand the existing of the emerging epidemiological data of comorbidities among preterm infants.</p>
            </sec>
            <sec id="sec10">
                <title>Study design and population</title>
                <p>This retrospective study included 201 preterm infants who were diagnosed with IVH by cranial ultrasonography and were born at or before 37 weeks of gestational age (GA) between 2016 and 2023 at King Fahd University Hospital in Khobar, Saudi Arabia. After 72 to 96 hours of life, and then every week until discharge, newborns with a gestational age of less than 34 weeks and a birth weight of less than 1500 g were screened using cranial ultrasonography.</p>
            </sec>
            <sec id="sec11">
                <title>Inclusion criteria</title>
                <p>

                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Age &lt; 28 days old</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Both gender (male, female)</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Saudi and non-Saudi</p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec12">
                <title>Exclusion criteria</title>
                <p>

                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Age &gt; 28 days old</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Birth weight &gt; 1500 g</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Gestational age &gt; 34 weeks</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Outborn neonates</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Genetic syndromes</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Congenital malformation</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Died before cranial ultrasound examination</p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec13">
                <title>Data collection</title>
                <p>The diagnosis and classification of IVH were based on those of Papile
                    <sup>
                        <xref ref-type="bibr" rid="ref7">7</xref>
                    </sup>:</p>
                <p>Grade I: Germinal matrix hemorrhage.</p>
                <p>Grade II: As intraventricular hemorrhage without ventricular dilatation.</p>
                <p>Grade III: Intraventricular hemorrhage filling more than 50% of the ventricle and with ventricular dilatation.</p>
                <p>Grade IV: Intraparenchymal hemorrhage.</p>
                <p>Neonatal characteristics (gestational age, birth weight, gender, 5-min Apgar score, mode of delivery) and maternal characteristics (pregnancy hypertension, placental abruption, gestational diabetes, abnormal amniotic fluid, fetal distress, premature rupture of membranes) as well as neonatal complications (respiratory distress syndrome (RDS), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), periventricular leukomalacia (PVL), sepsis, and severe anemia) were considered to have a potential impact on IVH in preterm infants.</p>
            </sec>
            <sec id="sec14">
                <title>Data analysis</title>
                <p>Descriptive statistics were presented using numbers and percentages for all categorical variables. Univariate analysis was performed to determine the factors that influence IVH. Significant results were then tested in a multivariate regression analysis to determine the significant independent predictors associated with IVH in preterm infants, with corresponding odd ratios and 95% confidence intervals. Statistical significance was set to p&lt;0.05 level. All data analyses were performed using Statistical Packages for Social Sciences (SPSS) version 26 Armonk, NY: IBM Corporation.</p>
            </sec>
            <sec id="sec15">
                <title>Ethics</title>
                <p>Investigators will access the patients&#x2019; information from their medical records, by a permission obtained from the hospital administration. Informed consent was not required since the study will be retrospective and performed by a chart review without any potential risk implicated upon the patients. Confidentiality, deidentification, and anonymity of personal data will be strictly maintained all throughout.</p>
            </sec>
        </sec>
        <sec id="sec16" sec-type="results">
            <title>Results</title>
            <p>This study reviewed two hundred and one preterm infants. As described in (
                <xref ref-type="table" rid="T1">
Table 1</xref>), 50.7% were males. Regarding maternal characteristics, 51.2% had a gestational age of 29 weeks or less. The most common method of delivery was caesarean (63.2%). Half of the mothers had a maternal age of over 30 years. Birth patterns were mostly singleton (77.6%).</p>
            <table-wrap id="T1" orientation="portrait" position="float">
                <label>
Table 1. </label>
                <caption>
                    <title>Biographical data maternal and neonatal 
                        <sup>(n=201)</sup>.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Study variables</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
Number (%)</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Gender</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Male</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">102 (50.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Female</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">99 (49.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Gestational age</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;29 weeks</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">103 (51.2%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;29 weeks</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">98 (48.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth weight</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;1200 gram</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">109 (54.2%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;1200 gram</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">92 (45.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Mode of delivery</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Caesarean section</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">127 (63.2%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Normal vaginal delivery</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">74 (36.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Maternal age</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;30 years</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">100 (49.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;30 years</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">101 (50.2%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth pattern</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Single</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">156 (77.6%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Twin</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">32 (15.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Triplet</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">13 (06.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Follow-up
</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">139 (69.2%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">62 (30.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Multiple birth</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">100 (48.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">101 (50.2%)</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>(
                <xref ref-type="table" rid="T2">
Table 2</xref>) shows the medical characteristics of the comorbidities of the patients. About 87.1% were diagnosed with septicemia, and 14.9% had NEC. The incidence of IVH was 41.8%, with grade 1 being the most common reported (41.7%). BPD, CHD, hydrocephalus, RDS, seizure, PRBC, IUGR, jaundice, and PROM were seen in 16.9%, 38.3%, 3.5%, 88.1%, 6.5%, 48.3%, 14.9%, 62.7%, and 15.4%, respectively. ROP was 37.3%, with stage 1 being the most frequent (45.3%). DM, PIH, pre-eclampsia, hypothyroidism, IVF, chorioamnionitis, consanguinity, UTI, pneumothorax, pulmonary hemorrhage, and pulmonary hypertension were seen in 9.5%, 11.4%, 12.9%, 2%, 14.4%, 3%, 49.8%, 33.3%, 3%, 4.5%, and 6.5%, respectively. Regarding patient treatment and management, nearly all (95.5%) received antenatal steroids, while 7% received steroids during the postnatal period (7%). Surfactants were administered to 60.7% of the patients of them, 41.8% received a single dose. In addition, nearly half (44.3%) used oxygen for more than 28 days.</p>
            <table-wrap id="T2" orientation="portrait" position="float">
                <label>
Table 2. </label>
                <caption>
                    <title>Medical characteristics and comorbidities 
                        <sup>(n=201)</sup>.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Variables</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
N (%)</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Septicaemia</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">175 (87.1%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Necrotizing enterocolitis (NEC)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">30 (14.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Intraventricular haemorrhage (IVH)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">84 (41.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">IVH level 
                                <sup>(n=84)</sup>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Grade 1</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">35 (41.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Grade 2</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">29 (34.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Grade 3</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">12 (14.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Grade 4</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">05 (06.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Not specified</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">03 (03.6%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Bronchopulmonary dysplasia (BPD)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">34 (16.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Congenital heart disease (CHD)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">77 (38.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Hydrocephalus</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">07 (03.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Respiratory Distress Syndrome (RDS)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">177 (88.1%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Seizure</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">13 (06.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Packed red blood cells (PRBC) transfusion</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">97 (48.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Intrauterine growth restriction (IUGR)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">30 (14.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Jaundice</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">126 (62.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Retinopathy of prematurity (ROP)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">75 (37.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">ROP stage</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Stage 0</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">01 (01.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Stage 1</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">34 (45.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Stage 2</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">24 (32.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Stage 3</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">16 (21.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Premature rupture of membranes (PROM)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">31 (15.4%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Diabetes mellitus (DM)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">19 (09.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pregnancy-induced hypertension (PIH)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">23 (11.4%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pre-eclampsia
</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">26 (12.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Hypothyroidism</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">04 (02.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">In vitro fertilization</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">29 (14.4%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Chorioamnionitis</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">06 (03.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Consanguinity</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">100 (49.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Urinary Tract Infection</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">67 (33.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pneumothorax</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">06 (03.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pulmonary hemorrhage</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">09 (04.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pulmonary hypertension</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">13 (06.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="2" rowspan="1" valign="top">
                                <bold>Management</bold>
</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Antenatal steroid</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">09 (04.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">192 (95.5%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Postnatal steroid</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">187 (93.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">14 (07.0%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Surfactant</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">79 (39.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">122 (60.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Surfactant dose 
                                <sup>(n=122)</sup>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; 1 dose</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">51 (41.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; 2 doses</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">29 (23.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; 3 doses</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">05 (04.1%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Not specified</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">37 (30.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">O2 duration</td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &lt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">112 (55.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">89 (44.3%)</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>In (
                <xref ref-type="table" rid="T3">
Table 3</xref>) the incidence of IVH was significantly more common among patients with a birth weight of 1200 g or less (p=0.001), those who were born by NVD method (p=0.007), increasing duration of oxygen used (p&lt;0.001), septicemia (p=0.003), CHD (p&lt;0.001), RDS (p=0.002), seizure (p=0.008), PRBC (p&lt;0.001), jaundice (p&lt;0.001), ROP (p&lt;0.001), and consanguinity (p&lt;0.001).</p>
            <table-wrap id="T3" orientation="portrait" position="float">
                <label>
Table 3. </label>
                <caption>
                    <title>Univariate analysis for the predictors of IVH in preterm infants 
                        <sup>(n=201)</sup>.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="2" valign="top">Factor</th>
                            <th align="left" colspan="2" rowspan="1" valign="top">IVH</th>
                            <th align="left" colspan="1" rowspan="2" valign="top">
P-value 
                                <xref ref-type="table-fn" rid="tfn1">
                                    <sup>&#x00a7;</sup>
                                </xref>
                            </th>
                        </tr>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Yes N (%) 
                                <sup>(n=84)</sup>
                            </th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
No N (%) 
                                <sup>(n=117)</sup>
                            </th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Gender</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Male</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">44 (52.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">58 (49.6%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.694</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Female</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">40 (47.6%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">59 (50.4%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Gestational age</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;29 weeks</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">49 (58.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">54 (46.2%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.088</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;29 weeks</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">35 (41.7%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">63 (53.8%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth weight</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;1200 g</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">57 (67.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">52 (44.4%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;1200 g</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">27 (32.1%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">65 (55.6%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Mode of delivery</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Caesarean section</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">44 (52.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">83 (70.9%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>0.007</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Normal vaginal delivery</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">40 (47.6%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">34 (29.1%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Maternal age</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;30 years</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">37 (44.0%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">64 (54.7%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.136</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;30 years</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">47 (56.0%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">53 (45.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">40 (47.6%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">57 (48.7%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.878</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">44 (52.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">60 (51.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Multiple birth</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">43 (51.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">57 (48.7%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.730</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">41 (48.8%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">60 (51.3%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth pattern</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Single</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">64 (76.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">92 (78.6%)</td>
                            <td align="left" colspan="1" rowspan="3" valign="middle">0.455</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Twin</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">16 (19.0%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">16 (13.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Triplet</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">04 (04.8%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">09 (07.7%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">O2 duration</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &lt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">30 (35.7%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">82 (70.1%)</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">54 (64.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">35 (29.9%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Follow-up
</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">38 (45.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">24 (20.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Antenatal steroid</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">78 (92.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">114 (97.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.122</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Postnatal steroid</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">07 (08.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">07 (06.0%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.519</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Surfactant</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">65 (77.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">57 (48.7%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Septicemia</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">80 (95.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">95 (81.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0.003</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Necrotizing enterocolitis (NEC)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">13 (15.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">17 (14.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.853</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Bronchopulmonary dysplasia (BPD)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">18 (21.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">16 (13.7%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.148</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Congenital heart disease (CHD)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">52 (61.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">25 (21.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Respiratory Distress Syndrome (RDS)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">81 (96.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">96 (82.1%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0.002</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Seizure</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">10 (11.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">03 (02.6%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0.008</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Packed red blood cells (PRBC) transfusion</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">54 (64.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">43 (36.8%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Intrauterine growth restriction (IUGR)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">12 (14.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">18 (15.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.829</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Jaundice</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">67 (79.8%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">59 (50.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Retinopathy of prematurity (ROP)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">49 (58.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">26 (22.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Premature rupture of membranes (PROM)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">12 (14.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">19 (16.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.705</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Diabetes mellitus (DM)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">08 (09.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">11 (09.4%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.977</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pregnancy-induced hypertension (PIH)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">10 (11.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">13 (11.1%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.862</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Pre-eclampsia
</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">13 (15.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">13 (11.1%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.363</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">In vitro fertilization</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">10 (11.9%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">19 (16.2%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.388</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Consanguinity</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">55 (65.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">45 (38.5%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn2">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Urinary Tract Infection</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">33 (39.3%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">34 (29.1%)</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.129</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <fn-group content-type="footnotes">
                        <fn id="tfn1">
                            <label>
                                <sup>&#x00a7;</sup>
                            </label>
                            <p>P-value has been calculated using Chi-square test.</p>
                        </fn>
                        <fn id="tfn2">
                            <label>**</label>
                            <p>Significant at p&lt;0.05 level.</p>
                        </fn>
                    </fn-group>
                </table-wrap-foot>
            </table-wrap>
            <p>A multivariate regression analysis was subsequently performed in (
                <xref ref-type="table" rid="T4">
Table 4</xref>) to determine the significant independent predictors of IVH. Based on the results, it was found that patients with CHD were predicted to increase the risk of having IVH by at least 4.27 times higher (AOR=4.272; 95% CI=1.987 &#x2013; 9.183; p&lt;0.001). Patients with seizures were at increased risk of having IVH by almost 5.5 times higher (AOR=5.496; 95% CI=1.208 &#x2013; 24.996; p=0.027). Also, patients who had ROP were at increased risk of having IVH by at least 3.2-fold higher (AOR=3.158; 95% CI = 1.057 &#x2013; 9.349; p=0.039). No significant effects were observed between the incidence of IVH in relation to birth weight, mode of delivery, O2 duration, follow-up, surfactant used, septicemia, RDS, PRBC, jaundice, and consanguinity after adjustment to a regression model (p&gt;0.05).</p>
            <table-wrap id="T4" orientation="portrait" position="float">
                <label>
Table 4. </label>
                <caption>
                    <title>Multivariate regression analysis to determine significant independent predictors of IVH in preterm infants 
                        <sup>(n=201)</sup>.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Factor</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">AOR</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">95% CI</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
P-value
</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Birth weight</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &#x2264;1200 g</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;1200 g</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.980</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.428 &#x2013; 2.243</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.962</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Mode of delivery</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; CS</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; NVD</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.994</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.980 &#x2013; 4.059</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.057</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">O2 duration</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &lt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; &gt;28 days</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.195</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.468 &#x2013; 3.051</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.710</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Follow-up
</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.808</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.284 &#x2013; 2.304</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.690</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Surfactant</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.129</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.433 &#x2013; 2.939</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.804</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Septicemia</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.994</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.224 &#x2013; 4.400</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.993</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Congenital heart disease (CHD)</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.272</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">1.987 &#x2013; 9.183</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>&lt;0.001</bold> 
                                <xref ref-type="table-fn" rid="tfn3">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Respiratory Distress Syndrome (RDS)</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.921</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.369 &#x2013; 9.998</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.438</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Seizure</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">5.496</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">1.208 &#x2013; 24.996</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0.027</bold> 
                                <xref ref-type="table-fn" rid="tfn3">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Packed red blood cells (PRBC) transfusion</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.596</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.226 &#x2013; 1.575</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.297</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Jaundice</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.886</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.839 &#x2013; 4.239</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.125</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Retinopathy of prematurity (ROP)</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3.158</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">1.057 &#x2013; 9.439</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0.039</bold> 
                                <xref ref-type="table-fn" rid="tfn3">

                                    <bold>**</bold>
                                </xref>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">Consanguinity</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; No</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Ref</td>
                            <td colspan="1" rowspan="1"/>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">&#x2003;&#x2022; Yes</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.232</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.536 &#x2013; 2.830</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">0.623</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <p>AOR &#x2013; Adjusted Odds Ratio; CI &#x2013; Confidence Interval.</p>
                    <fn-group content-type="footnotes">
                        <fn id="tfn3">
                            <label>**</label>
                            <p>Significant at p&lt;0.05 level.</p>
                        </fn>
                    </fn-group>
                </table-wrap-foot>
            </table-wrap>
        </sec>
        <sec id="sec17" sec-type="discussion">
            <title>Discussion</title>
            <p>This study explores the incidence of IVH among preterm infants born between 01 January 2016 and 01 January 2023 at King Fahad Hospital of The University, Khobar, Saudi Arabia. The results showed that among the 207 preterm infants collected, 84 of them had IVH, and the overall incidence was 41.8%. IVH grade mainly was mild (grade 1 + grade 2: 76.2%), and only 20.3% were classified as severe (grade 3 + grade 4). This is strikingly similar to that of Maduray et al. (2019).
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>
                </sup> Study documented an IVH prevalence of 67% and 44.3% detected among VLBW and LBW infants. Consistent with these reports, Sisenda et al. (2022)
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup> indicated that the one-year prevalence of IVH among preterm neonates was 33.8%, mainly mild (67.6%) followed by severe (32.4%). According to the systematic review of Siffel et al. (2021),
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup> the worldwide incidence of IVH grade 3/4 ranges between 5% and 52%. Considering population-based studies, the rate of IVH grade 3/4 was between 6% and 22%. Lower IVH grades, however, were rarely documented, but they evolved between 5% and 19%.</p>
            <p>Based on our univariate analysis, low birth weight is a predictor of IVH among preterm infants; however, this did not remain significant in a multivariate regression model (p=0.972). Further, we found a higher prevalence of IVH among those who were born through NVD, have over 28 days of O2 use, those who have required follow-ups, and those with septicemia, NEC, RDS, PRBC, jaundice, PROM, and consanguinity. However, we did not find an association between IVH in terms of gender, maternal age, multiple births, birth patterns, and gestational age (p&gt;0.05). This contradicted the reports of a study done in South Africa, suggesting that birth weight and gestational were significantly associated with IVH.
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup> In Nigeria, lower gestational age (&lt;32 weeks gestation), low Apgar scores, need for respiratory support, lower social class, outborn status of neonates, and blood transfusion were recognized as predictors of IVH.
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup> Consistent with these reports, a study published in Canada also recognized weight and small birth gestation as risk factors for IVH. Other important predictors identified in the study were insufficiency of antenatal corticosteroids, chorioamnionitis, Apgar score, RDS, prolonged intubation, early-onset sepsis, hypercapnia, pCO2 fluctuations, inhaled nitric oxide, inotropes or normal saline boluses, bicarbonate/THAM therapy opioids infusions, and metabolic derangements.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup>
            </p>
            <p>In our multivariate regression estimates, only CHD, seizure, and ROP remained significant and were determined to be the independent risk factors for IVH. In Portugal, multivariate regression estimates that the significant risk factors for Germinal Matrix Hemorrhage (GMH)-IVH include resuscitation exposure in the delivery room, visual impairment, and gross motor and locomotor dysfunction.
                <sup>
                    <xref ref-type="bibr" rid="ref17">17</xref>
                </sup> In Poland, multivariate analysis suggested that the more risk factors present, the greater the risk of severe IVH degrees, particularly in children born before 32 weeks of gestation and without AST and born with asphyxia and hypotension and with acidosis. In addition, grade 3 and 4 IVH were linked to increased mortality in preterm infants.
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>,
                    <xref ref-type="bibr" rid="ref13">13</xref>,
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup>
            </p>
            <p>IVH, particularly those severe ones, is a serious condition that develops between the perinatal and postnatal periods. Identifying the occurrence of IVH is a criterion for its antecedents and then applying preventive actions.
                <sup>
                    <xref ref-type="bibr" rid="ref19">19</xref>
                </sup> In our study, antennal steroids were the most prominent treatment being administered to patients. However, steroid use was not identified as a predictive factor for IVH (p=0.122). This did not coincide with the study done in Kenya,
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup> suggesting that the use of antennal steroids was associated with decreasing IVH risk. A previous study done in Poland supported these reports.
                <sup>
                    <xref ref-type="bibr" rid="ref20">20</xref>
                </sup> Incomplete or no antenatal steroid therapy could lead to the progression of IVH. Hence, steroid therapy should be considered to be given to women at risk of premature delivery. The implication of IVH magnifies the need to conduct a regional periodical analysis concerning its incidence, causes, and impacts to enhance local treatment outcomes by recognizing courses of action.
                <sup>
                    <xref ref-type="bibr" rid="ref20">20</xref>
                </sup>
            </p>
            <sec id="sec18">
                <title>Limitation</title>
                <p>We acknowledge that there were limitations to our study. It was observational, so it is difficult to assume causality. Even though we made an effort to control for confounding variables. The second limitation of our study was the follow-up at 18&#x2013;24 months of corrected age. Further evaluation of the effect of IVH on neurological outcomes in preterm infants requires follow-ups until school age or even longer. Findings from a single-center study with a small number of infants included and a brief follow-up period are additional study limitations. Therefore, it is advised that future multi-center studies with a large patient population use complementary imaging. This information would have further aided in the management planning of these cases.</p>
            </sec>
        </sec>
        <sec id="sec19" sec-type="conclusion">
            <title>Conclusion</title>
            <p>There was a high incidence of IVH among preterm infants during the last 7 years. Patients with CHD, seizure, and ROP were the most susceptible to IVH as compared to other preterm infants. Hence, continuous monitoring is vital among these groups of patients, and finding new therapeutic strategies aimed at reducing the serious consequences of IVH is warranted. The factors identified in this study can be considered clinically relevant and subjected to further investigation. Screening and early detection of brain injury among high-risk neonates are crucial to facilitate necessary treatment and management associated with adverse chronic neurodevelopmental outcomes.</p>
        </sec>
        <sec id="sec20">
            <title>Ethics and consent</title>
            <p>This research project was approved by institutional review board of King Fahd Hospital of the University (May 26, 2024) [Certificate# REC-2024-NOV-ETHICS405]. Participants&#x2019; information was kept confidential and anonymous. Informed consent was not required since the study will be retrospective.</p>
        </sec>
        <sec id="sec21">
            <title>Pre-print citation</title>
            <p>AlGhamdi M, Alnaim A, Al Ghadeer H, Aldajani A, Alabdulqader M, Alarbash A, Alkhamis A, AlBassam L, AlQahtani F, Abdulghani D, Al Noaim K, Alahmari A, Alhejji M, Alamer E, Aldandan H. The Prevalence Of Intraventricular Hemorrhage And Its Related Risk Factors Among Preterm Neonates. Figshare [Preprint]. 2025 [cited 2025 MAY 6]. Available from: 
                <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.28731242">https://doi.org/10.6084/m9.figshare.28731242</ext-link>.</p>
        </sec>
    </body>
    <back>
        <sec id="sec24" sec-type="data-availability">
            <title>Data availability statement</title>
            <sec id="sec25">
                <title>Underlying data</title>
                <p>Figshare: The Prevalence Of Intraventricular Hemorrhage And Its Related Risk Factors Among Preterm Neonates, 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.28731242">https://doi.org/10.6084/m9.figshare.28731242</ext-link>.
                    <sup>
                        <xref ref-type="bibr" rid="ref21">21</xref>
                    </sup>
                </p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Data.xlsx</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Behrman</surname>
                            <given-names>RE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Butler</surname>
                            <given-names>AS</given-names>
                        </name>
</person-group>:
                    <article-title>Preterm birth: causes, consequences, and prevention.</article-title>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kadri</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mawla</surname>
                            <given-names>AA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kazah</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>The incidence, timing, and predisposing factors of germinal matrix and intraventricular hemorrhage (GMH/IVH) in preterm neonates.</article-title>
                    <source>

                        <italic toggle="yes">Childs Nerv. Syst.</italic>
</source>
                    <year>2006 Sep</year>;<volume>22</volume>:<fpage>1086</fpage>&#x2013;<lpage>1090</lpage>.
                    <pub-id pub-id-type="pmid">16636880</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00381-006-0050-6</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chevallier</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Debillon</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pierrat</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Leading causes of preterm delivery as risk factors for intraventricular hemorrhage in very preterm infants: results of the EPIPAGE 2 cohort study.</article-title>
                    <source>

                        <italic toggle="yes">Am. J. Obstet. Gynecol.</italic>
</source>
                    <year>2017 May 1</year>;<volume>216</volume>(<issue>5</issue>):<fpage>518.e1</fpage>&#x2013;<lpage>518.e12</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.ajog.2017.01.002</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Song</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>X</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The impact of different degrees of intraventricular hemorrhage on mortality and neurological outcomes in very preterm infants: a prospective cohort study.</article-title>
                    <source>

                        <italic toggle="yes">Front. Neurol.</italic>
</source>
                    <year>2022 Mar 21</year>;<volume>13</volume>:<fpage>853417</fpage>.
                    <pub-id pub-id-type="pmid">35386416</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fneur.2022.853417</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8978798</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Deshpande</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jain</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ibarra R&#x00ed;os</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Combined multimodal cerebral monitoring and focused hemodynamic assessment in the first 72 h in extremely low gestational age infants.</article-title>
                    <source>

                        <italic toggle="yes">Neonatology.</italic>
</source>
                    <year>2020 Dec 2</year>;<volume>117</volume>(<issue>4</issue>):<fpage>504</fpage>&#x2013;<lpage>512</lpage>.
                    <pub-id pub-id-type="pmid">32814317</pub-id>
                    <pub-id pub-id-type="doi">10.1159/000508961</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ferreira</surname>
                            <given-names>DM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gir&#x00e3;o</surname>
                            <given-names>AL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>e Silva</surname>
                            <given-names>AV</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Application of a bundle in the prevention of peri-intraventricular hemorrhage in preterm newborns.</article-title>
                    <source>

                        <italic toggle="yes">J. Perinat. Neonatal Nurs.</italic>
</source>
                    <year>2020 Apr 1</year>;<volume>34</volume>(<issue>2</issue>):<fpage>E5</fpage>&#x2013;<lpage>E11</lpage>.
                    <pub-id pub-id-type="pmid">32332449</pub-id>
                    <pub-id pub-id-type="doi">10.1097/JPN.0000000000000482</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Papile</surname>
                            <given-names>LA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Burstein</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Burstein</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.</article-title>
                    <source>

                        <italic toggle="yes">J. Pediatr.</italic>
</source>
                    <year>1978 Apr 1</year>;<volume>92</volume>(<issue>4</issue>):<fpage>529</fpage>&#x2013;<lpage>534</lpage>.
                    <pub-id pub-id-type="pmid">305471</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0022-3476(78)80282-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wu</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Xiong</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Risk factors for the deterioration of periventricular&#x2013;intraventricular hemorrhage in preterm infants.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Rep.</italic>
</source>
                    <year>2020 Aug 12</year>;<volume>10</volume>(<issue>1</issue>):<fpage>13609</fpage>.
                    <pub-id pub-id-type="pmid">32788671</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41598-020-70603-z</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7423930</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Radic</surname>
                            <given-names>JA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vincer</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McNeely</surname>
                            <given-names>PD</given-names>
                        </name>
</person-group>:
                    <article-title>Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010.</article-title>
                    <source>

                        <italic toggle="yes">J. Neurosurg. Pediatr.</italic>
</source>
                    <year>2015 Jun 1</year>;<volume>15</volume>(<issue>6</issue>):<fpage>580</fpage>&#x2013;<lpage>588</lpage>.
                    <pub-id pub-id-type="doi">10.3171/2014.11.PEDS14364</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Novak</surname>
                            <given-names>CM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ozen</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Burd</surname>
                            <given-names>I</given-names>
                        </name>
</person-group>:
                    <article-title>Perinatal brain injury: mechanisms, prevention, and outcomes.</article-title>
                    <source>

                        <italic toggle="yes">Clin. Perinatol.</italic>
</source>
                    <year>2018 Jun 1</year>;<volume>45</volume>(<issue>2</issue>):<fpage>357</fpage>&#x2013;<lpage>375</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.clp.2018.01.015</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Stoll</surname>
                            <given-names>BJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hansen</surname>
                            <given-names>NI</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bell</surname>
                            <given-names>EF</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.</article-title>
                    <source>

                        <italic toggle="yes">Pediatrics.</italic>
</source>
                    <year>2010 Sep 1</year>;<volume>126</volume>(<issue>3</issue>):<fpage>443</fpage>&#x2013;<lpage>456</lpage>.
                    <pub-id pub-id-type="pmid">20732945</pub-id>
                    <pub-id pub-id-type="doi">10.1542/peds.2009-2959</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2982806</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Maduray</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mamdoo</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Masekela</surname>
                            <given-names>R</given-names>
                        </name>
</person-group>:
                    <article-title>A retrospective study on the prevalence, severity and outcomes of intraventricular haemorrhage in infants with a low birth weight in a quarternary hospital in a low-to middle-income country.</article-title>
                    <source>

                        <italic toggle="yes">S. Afr. J. Child Health.</italic>
</source>
                    <year>2019 Jun 1</year>;<volume>13</volume>(<issue>2</issue>):<fpage>56</fpage>&#x2013;<lpage>62</lpage>.</mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sisenda</surname>
                            <given-names>GN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Njuguna</surname>
                            <given-names>FM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nyandiko</surname>
                            <given-names>WM</given-names>
                        </name>
</person-group>:
                    <article-title>Prevalence of intraventricular haemorrhage and determinants of its early outcomes among preterm neonates at the newborn unit of a teaching hospital in Western Kenya.</article-title>
                    <source>

                        <italic toggle="yes">medRxiv.</italic>
</source>
                    <year>2022 Mar 18</year>;<fpage>2003</fpage>&#x2013;<lpage>2022</lpage>.</mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Siffel</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kistler</surname>
                            <given-names>KD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sarda</surname>
                            <given-names>SP</given-names>
                        </name>
</person-group>:
                    <article-title>Global incidence of intraventricular hemorrhage among extremely preterm infants: a systematic literature review.</article-title>
                    <source>

                        <italic toggle="yes">J. Perinat. Med.</italic>
</source>
                    <year>2021 Nov 25</year>;<volume>49</volume>(<issue>9</issue>):<fpage>1017</fpage>&#x2013;<lpage>1026</lpage>.
                    <pub-id pub-id-type="pmid">33735943</pub-id>
                    <pub-id pub-id-type="doi">10.1515/jpm-2020-0331</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Egwu</surname>
                            <given-names>CC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ogala</surname>
                            <given-names>WN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Farouk</surname>
                            <given-names>ZL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Factors associated with intraventricular hemorrhage among preterm neonates in Aminu Kano teaching hospital.</article-title>
                    <source>

                        <italic toggle="yes">Niger. J. Clin. Pract.</italic>
</source>
                    <year>2019 Mar 1</year>;<volume>22</volume>(<issue>3</issue>):<fpage>298</fpage>&#x2013;<lpage>304</lpage>.
                    <pub-id pub-id-type="pmid">30837415</pub-id>
                    <pub-id pub-id-type="doi">10.4103/njcp.njcp_154_18</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Khanafer-Larocque</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Soraisham</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Stritzke</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Intraventricular hemorrhage: risk factors and association with patent ductus arteriosus treatment in extremely preterm neonates.</article-title>
                    <source>

                        <italic toggle="yes">Front. Pediatr.</italic>
</source>
                    <year>2019 Oct 22</year>;<volume>7</volume>:<fpage>408</fpage>.
                    <pub-id pub-id-type="pmid">31696098</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fped.2019.00408</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6817605</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Reis</surname>
                            <given-names>JS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pereira</surname>
                            <given-names>IA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lira</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Intraventricular hemorrhage in preterm infants: risk factors and neurodevelopmental outcomes.</article-title>
                    <source>

                        <italic toggle="yes">J. Pediatric Neonatal Individ. Medicine.</italic>
</source>
                    <year>2023 Jan 16</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e120118</fpage>.</mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Piccolo</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Marchignoli</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pisani</surname>
                            <given-names>F</given-names>
                        </name>
</person-group>:
                    <article-title>Intraventricular hemorrhage in preterm newborn: Predictors of mortality.</article-title>
                    <source>

                        <italic toggle="yes">Acta Bio Medica: Atenei Parmensis.</italic>
</source>
                    <year>2022</year>;<volume>93</volume>(<issue>2</issue>).</mixed-citation>
            </ref>
            <ref id="ref19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gupta</surname>
                            <given-names>AK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Anand</surname>
                            <given-names>NK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lamba</surname>
                            <given-names>IM</given-names>
                        </name>
</person-group>:
                    <article-title>Ultrasonic evaluation of neonatal subependymal-intraventricular hemorrhage and its complications.</article-title>
                    <source>

                        <italic toggle="yes">Indian J. Pediatr.</italic>
</source>
                    <year>1993 Jan</year>;<volume>60</volume>:<fpage>11</fpage>&#x2013;<lpage>18</lpage>.
                    <pub-id pub-id-type="pmid">8244471</pub-id>
                    <pub-id pub-id-type="doi">10.1007/BF02860497</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Szpecht</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Szymankiewicz</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nowak</surname>
                            <given-names>I</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Intraventricular hemorrhage in neonates born before 32 weeks of gestation&#x2014;retrospective analysis of risk factors.</article-title>
                    <source>

                        <italic toggle="yes">Childs Nerv. Syst.</italic>
</source>
                    <year>2016 Aug</year>;<volume>32</volume>:<fpage>1399</fpage>&#x2013;<lpage>1404</lpage>.
                    <pub-id pub-id-type="pmid">27236782</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00381-016-3127-x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4967094</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <label>21</label>
                <mixed-citation publication-type="data">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>AlGhadeer</surname>
                            <given-names>H</given-names>
                        </name>
</person-group>:
                    <data-title>The Prevalence Of Intraventricular Hemorrhage And Its Related Risk Factors Among Preterm Neonates.</data-title>Dataset.
                    <source>

                        <italic toggle="yes">figshare.</italic>
</source>
                    <year>2025</year>.
                    <pub-id pub-id-type="doi">10.6084/m9.figshare.28731242.v1</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>
